▟ Vinebot intrinsic value, daily

← back

DGX Quest Diagnostics

healthcare · valued with glm-5.2 medium conviction · deep-dived 2026-08-31

HOLD
Intrinsic value$123.02
Price (at call)$242.76
Margin of safety -49.3%
vs market (rating basis) -3.7%

Model unavailable; showing baseline valuation.

⚠ LLM error: empty response; using baseline

The story

Value drivers

Revenue growth (Y1)3.7%
Terminal growth3.5%
Forecast horizon10y
Target operating margin14.5%
Years to target margin5
Sales-to-capital0.89
Beta0.55
Failure probability0.0%
Cost of capital (WACC)6.9%
Terminal WACC8.6%

Valuation bridge

PV of explicit FCFF6.94B
PV of terminal value12.29B
Equity value13.58B
÷ shares → per share$123.02

News

neutral +0.10 · 8 articles

  • Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
  • Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?
  • Roche and Eli Lilly Win FDA Clearance for Alzheimer’s Blood Test
  • Beat the Market Like Zacks: Amgen, FirstCash, Delek in Focus
  • Is it the Right Time to Retain DGX Stock in Your Portfolio?
  • Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
  • Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash
  • Quest Diagnostics (DGX) Could Be 30% Below Fair Value After Upgrade And WHOOP Deal

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 11.99B 3.7% 14.5% 1.32B 488.31M 833.82M 780.12M
2 12.44B 3.7% 14.5% 1.37B 502.93M 868.34M 760.09M
3 12.90B 3.7% 14.5% 1.42B 517.82M 904.04M 740.37M
4 13.37B 3.7% 14.5% 1.47B 532.99M 940.95M 720.97M
5 13.86B 3.6% 14.5% 1.53B 548.43M 979.09M 701.88M
6 14.36B 3.6% 14.5% 1.58B 564.13M 1.02B 683.11M
7 14.87B 3.6% 14.5% 1.64B 580.10M 1.06B 664.65M
8 15.40B 3.6% 14.5% 1.70B 596.34M 1.10B 646.52M
9 15.94B 3.5% 14.5% 1.76B 612.83M 1.14B 628.71M
10 16.50B 3.5% 14.5% 1.82B 629.58M 1.19B 611.22M

History

DatePriceIntrinsicMoSRating
2026-08-31$242.76 $123.02 -49.3% HOLD
2026-07-09$208.21 $109.43 -47.4% HOLD
2026-06-23$197.18 $112.84 -42.8% HOLD